The single greatest safety risk is not the compound itself but unverified sourcing: contamination, mislabeling, and inconsistent purity in the research peptide market make clinical supervision and verified supply chains non-negotiable
When medication is appropriate, follow-up visits support monitoring, side-effect conversations, and adjustments within a broader plan that may include nutrition, movement, sleep, and other medical care
8.2 Advanced Imaging of Cervical-Vestibular Coupling New dynamic MRI techniques are capturing real-time CSF flow and vertebral artery pulsatility at C1/C2correlating misalignment degrees with functional deficits
Book an appointment or call us today to get your B12 shot or Vitamin D injection
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects